CRISPR Therapeutics

CRSP

Rank 2079

Country USA

Exchange NASDAQ

Currency USD

Sector LIFE SCIENCES

Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Address BAARERSTRASSE 14, ZUG, CH

CRISPR Therapeutics - Key figures

Market cap 4.85 Billion

Revenue 915.36 Million

Profit 476.33 Million

P/E Ratio 16.21

P/s Ratio 5.29

CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases.

The company is headquartered in Zug, Switzerland.